-
2025-523895-22-00
4
Non-small cell lung cancer (NSCLC)
-
2025-524040-35-00
5
Severe uncontrolled asthma
-
2025-522007-18-00
5
2026-05-27
Relapsed or Refractory Multiple Myeloma
-
2025-521711-39-00
5
2026-05-17
Lewy body Dementia psychosis (LBDP)
-
2025-521074-34-00
4
2026-05-15
Allogeneic peripheral hematopoietic stem cell transplant
-
2024-519870-38-00
5
2026-05-11
Atherosclerotic cardiovascular disease (ASCVD)
-
2025-524498-17-00
10
2026-05-08
Pretreated Unresectable Locally Advanced or Metastatic human epidermal
-
2023-508047-40-00
5
2026-04-30
Ovarian cancer
-
2025-520466-22-00
5
2026-04-29
Advanced Platinum-resistant Epithelial Ovarian Cancer
-
2024-519699-24-00
4
2026-04-23
IgA nephropathy
-
2025-521521-33-00
10
2026-04-02
Kidney transplant rejection
-
2025-523533-25-00
10
2026-03-26
Cancer-associated Cachexia
-
2025-521314-25-00
5
2026-03-19
NPM1-m and KMT2A-r Acute Myeloid Leukemia
-
2024-519444-33-00
5
2026-03-12
HER2-expressing endometrial cancer (IHC 3+/2+)
-
2025-523037-25-00
4
2026-03-10
Patients at high risk for Cardiac Surgery Associated – Acute Kidney In
-
2025-521919-39-00
3
2026-02-10
Resected stage IIB, IIC, or III melanoma requiring adjuvant treatment
-
2025-521514-26-00
5
2026-01-26
Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer W
-
2025-521852-45-00
4
2026-01-22
Cutaneous T-Cell Lymphoma
-
2024-520337-80-00
5
2026-01-07
Palmoplantar Pustulosis
-
2024-518899-31-00
5
2025-12-19
Variant or wild-type transthyretin (TTR) amyloid cardiomyopathy
-
2024-519836-18-00
5
2025-12-16
treatment-resistant schizophrenia (TRS)
-
2024-516906-47-00
10
2025-11-28
Locally Advanced or Metastatic Urothelial Carcinoma
-
2025-520746-30-00
5
2025-11-18
Mild to moderate Alzheimer’s Disease
-
2024-518006-40-00
5
2025-11-13
Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD)